Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370459 · ClinicalTrials.gov registry record · NA
AFIX to Improve HPV Vaccination
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 223
- Enrollment target
NCT02370459 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 223 participants.
The verdict
NCT02370459, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
Study Summary
The University of North Carolina will test the effectiveness of the Centers for Disease Control and Prevention's AFIX model for increasing HPV vaccination coverage among adolescents. AFIX (Assessment, Feedback, Incentives and eXchange) consists of brief quality improvement consultations that immunization specialists from state health departments deliver to vaccine providers in primary care settings. Using immunization registry data, the specialist evaluates the clinic's vaccination coverage and delivers education on best practices to improve coverage. We will compare changes in HPV vaccination coverage before and after consultations for high-volume pediatric and family medicine clinics across three study conditions: traditional consultations (in-person group), virtual consultations (webinar group), or no consultations (control group). In each participating state, 30 clinics will be randomly assigned to each study arm, for a total of 90 clinics per state, or 270 clinics overall. The primary objective of this study is to compare the change in coverage for HPV vaccine initiation among 11-12 year old patients, from baseline to 6-month follow-up. Secondarily, we will compare the change in coverage for other vaccines and age groups.
Interventions
- OTHER AFIX in-person consultation
- OTHER AFIX webinar consultation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02370459
The ClinicalTrials.gov registry entry for NCT02370459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AFIX in-person consultation is the first listed.
NCT02370459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02370459 about?
NCT02370459 is a clinical study titled "AFIX to Improve HPV Vaccination". The University of North Carolina will test the effectiveness of the Centers for Disease Control and Prevention's AFIX model for increasing HPV vaccination coverage among adolescents. AFIX (Assessment, Feedback, Incentives and eXchange) consists of brief quality improvement consultations that immuniz...
What is the current status of trial NCT02370459?
This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2015-04. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02370459?
The interventions under investigation include: AFIX in-person consultation (OTHER), AFIX webinar consultation (OTHER).
Who is sponsoring clinical trial NCT02370459?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.